N,N-dimethyl-4-oxopiperidine-1-carboxamide, 98%, 250mg

N-ethylprop-2-ynamide, 95.0%, 1g

(1Z)-N'-hydroxy-2-(methylthio)ethanimidamide, 95.0%, 5g

(S)-Azepan-3-amine, 97%, 1g

(2R,4R)-4-methyl-1-[(2S)-2-(3-methylquinoline-8-sulfonamido)-5-(N''-nitrocarbamimidamido)pentanoyl]piperidine-2-carboxylic acid, 98%, 5g

Methyl 5-fluoropyrimidine-2-carboxylate, 95.0%, 1g

N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester, 97%, 250mg

(3aR,8aS)-3,3a,8,8a-Tetrahydro-2H-indeno[1,2-d]oxazol-2-one, 95.0%, 250mg

Benzyl trifluoroacetate, 5g

(2-(Thiophen-2-yl)phenyl)methanol, 98%, 250mg

Copper(II) 2-ethylhexanoate, 16.5-19%, 25g

Dipropylene glycol monobutyl ether, min 98%, for synthesis, 2.5 l, plastic packaging.

(2R,3R)-oxirane-2,3-dicarboxylic acid, 98%, 250mg